chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Heart rate, Myalgia, Nausea, Respiratory rate
Clinical narrative: Injection site warm to touch; Injection site pain; Injection site swelling; Fatigue; Chills; Headache; Muscle pain; Joint pain; Nausea; This spontaneous case was reported by a nurse and describes the occurrence of VACCINATION SITE WARMTH, VACCINATION SITE PAIN, VACCINATION SITE SWELLING, FATIGUE, and CHILLS in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, the patient experienced VACCINATION SITE WARMTH, VACCINATION SITE PAIN, VACCINATION SITE SWELLING, FATIGUE, CHILLS, HEADACHE, MYALGIA, ARTHRALGIA, and NAUSEA. At the time of the report, VACCINATION SITE WARMTH, VACCINATION SITE PAIN, VACCINATION SITE SWELLING, FATIGUE, CHILLS, HEADACHE, MYALGIA, ARTHRALGIA, and NAUSEA outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: 130/84 (High). On an unknown date, Body temperature: 97.9 (normal). On an unknown date, Heart rate: 82 (normal). On an unknown date, Respiratory rate: 16 (normal).     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was reported. No treatment medication was reported.   Most recent FOLLOW-UP information incorporated above includes: On 11-May-2021: Reporter details updated, patient demography updated, first dose details updated, event details were updated, lab data detail updated. On 16-Jul-2021: Email correspondence received and it contains No New Information.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Injection site warm to touch; Injection site pain; Injection site swelling; Fatigue; Chills; Headache; Muscle pain; Joint pain; Nausea; This spontaneous case was reported by a nurse and describes the occurrence of VACCINATION SITE WARMTH, VACCINATION SITE PAIN, VACCINATION SITE SWELLING, FATIGUE, and CHILLS in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, the patient experienced VACCINATION SITE WARMTH, VACCINATION SITE PAIN, VACCINATION SITE SWELLING, FATIGUE, CHILLS, HEADACHE, MYALGIA, ARTHRALGIA, and NAUSEA. At the time of the report, VACCINATION SITE WARMTH, VACCINATION SITE PAIN, VACCINATION SITE SWELLING, FATIGUE, CHILLS, HEADACHE, MYALGIA, ARTHRALGIA, and NAUSEA outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: 130/84 (High). On an unknown date, Body temperature: 97.9 (normal). On an unknown date, Heart rate: 82 (normal). On an unknown date, Respiratory rate: 16 (normal).     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was reported. No treatment medication was reported.   Most recent FOLLOW-UP information incorporated above includes: On 11-May-2021: Reporter details updated, patient demography updated, first dose details updated, event details were updated, lab data detail updated. On 16-Jul-2021: Email correspondence received and it contains No New Information.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Blister, Rash
Clinical narrative: rashes on the arm; rashes turned to blisters that dried up; This spontaneous case was reported by a consumer and describes the occurrence of RASH (rashes on the arm) and BLISTER (rashes turned to blisters that dried up) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Apr-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RASH (rashes on the arm) and BLISTER (rashes turned to blisters that dried up). At the time of the report, RASH (rashes on the arm) and BLISTER (rashes turned to blisters that dried up) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant product use was reported No treatment information was provided
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Erythema, Pruritus, Rash, Skin irritation, Vaccination site pruritus
Clinical narrative: If scratched the rash area becomes red; If scratched the rash area becomes irritated; Itching right forearm; Rash on his right forearm; Itching left forearm; Rash on his left forearm (injected Arm); This spontaneous case was reported by a consumer and describes the occurrence of SKIN IRRITATION (If scratched the rash area becomes irritated), PRURITUS (Itching right forearm), ERYTHEMA (If scratched the rash area becomes red), RASH (Rash on his right forearm) and VACCINATION SITE PRURITUS (Itching left forearm) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (Itching left forearm) and VACCINATION SITE RASH (Rash on his left forearm (injected Arm)). On 02-Apr-2021, the patient experienced PRURITUS (Itching right forearm) and RASH (Rash on his right forearm). On 12-Apr-2021, the patient experienced SKIN IRRITATION (If scratched the rash area becomes irritated) and ERYTHEMA (If scratched the rash area becomes red). At the time of the report, SKIN IRRITATION (If scratched the rash area becomes irritated), PRURITUS (Itching right forearm), ERYTHEMA (If scratched the rash area becomes red), RASH (Rash on his right forearm), VACCINATION SITE PRURITUS (Itching left forearm) and VACCINATION SITE RASH (Rash on his left forearm (injected Arm)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site rash
Clinical narrative: If scratched the rash area becomes red; If scratched the rash area becomes irritated; Itching right forearm; Rash on his right forearm; Itching left forearm; Rash on his left forearm (injected Arm); This spontaneous case was reported by a consumer and describes the occurrence of SKIN IRRITATION (If scratched the rash area becomes irritated), PRURITUS (Itching right forearm), ERYTHEMA (If scratched the rash area becomes red), RASH (Rash on his right forearm) and VACCINATION SITE PRURITUS (Itching left forearm) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (Itching left forearm) and VACCINATION SITE RASH (Rash on his left forearm (injected Arm)). On 02-Apr-2021, the patient experienced PRURITUS (Itching right forearm) and RASH (Rash on his right forearm). On 12-Apr-2021, the patient experienced SKIN IRRITATION (If scratched the rash area becomes irritated) and ERYTHEMA (If scratched the rash area becomes red). At the time of the report, SKIN IRRITATION (If scratched the rash area becomes irritated), PRURITUS (Itching right forearm), ERYTHEMA (If scratched the rash area becomes red), RASH (Rash on his right forearm), VACCINATION SITE PRURITUS (Itching left forearm) and VACCINATION SITE RASH (Rash on his left forearm (injected Arm)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Chest discomfort, Cough, Neck pain
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of CHEST DISCOMFORT (tightness in the chest), COUGH (coughed up some phlegm) and NECK PAIN (soreness in both sides of the neck) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination. Concurrent medical conditions included Hypertension and Heavy smoker. On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, the patient experienced CHEST DISCOMFORT (tightness in the chest), COUGH (coughed up some phlegm) and NECK PAIN (soreness in both sides of the neck). At the time of the report, CHEST DISCOMFORT (tightness in the chest) and COUGH (coughed up some phlegm) had resolved and NECK PAIN (soreness in both sides of the neck) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medications include Blood pressure medication. Treatment medication included Acetaminophen. Most recent FOLLOW-UP information incorporated above includes: On 14-May-2021: F/U received on 14-may-2021,Updated event outcome of neck pain from recovered to not recovered.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 antibody test, SARS-CoV-2 antibody test negative
Clinical narrative: Antibodies IGG test negative 2 weeks after second dose; This case was initially received via an unknown source (no reference has been entered for a health authority or license partner) on 12-Apr-2021. The most recent information was received on 01-Jul-2021 and was forwarded to Moderna on 01-Jul-2021.    This spontaneous case was reported by a patient family member or friend and describes the occurrence of SARS-COV-2 ANTIBODY TEST NEGATIVE (Antibodies IGG test negative 2 weeks after second dose) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031A21A and 030M20A) for COVID-19 vaccination.     Concurrent medical conditions included Glioblastoma. Concomitant products included APIXABAN (ELICUIS) from 15-Sep-2020 to an unknown date for an unknown indication.   On 26-Feb-2021 at 11:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Mar-2021 at 11:00 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced SARS-COV-2 ANTIBODY TEST NEGATIVE (Antibodies IGG test negative 2 weeks after second dose). At the time of the report, SARS-COV-2 ANTIBODY TEST NEGATIVE (Antibodies IGG test negative 2 weeks after second dose) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Apr-2021, SARS-CoV-2 antibody test: negative (Negative) IgG: Negative.         Treatment information was not provided by the reporter   Most recent FOLLOW-UP information incorporated above includes: On 01-Jul-2021: Significant Follow-up: Patient demographics updated, Concomitant product added
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Cystitis, Urinary tract infection
Clinical narrative: UTI; may have a bladder infection as she has some symptoms; This spontaneous case was reported by a consumer and describes the occurrence of CYSTITIS (may have a bladder infection as she has some symptoms) and URINARY TRACT INFECTION (UTI) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, the patient experienced CYSTITIS (may have a bladder infection as she has some symptoms). On an unknown date, the patient experienced URINARY TRACT INFECTION (UTI). The patient was treated with AZITHROMYCIN (AZO) for Adverse event, at an unspecified dose and frequency. At the time of the report, CYSTITIS (may have a bladder infection as she has some symptoms) and URINARY TRACT INFECTION (UTI) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided.   Most recent FOLLOW-UP information incorporated above includes: On 31-Jul-2021: Follow-up information received on 31-Jul-2021 and included Event UTI added with outcome. Treatment medication also added that was not included from original source document.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site rash
Clinical narrative: Rash at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (Rash at injection site) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, the patient experienced VACCINATION SITE RASH (Rash at injection site). At the time of the report, VACCINATION SITE RASH (Rash at injection site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure measurement, Dizziness, Tremor
Clinical narrative: hands started shaking; lightheaded; This spontaneous case was reported by a nurse and describes the occurrence of TREMOR (hands started shaking) and DIZZINESS (lightheaded) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039k20A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Apr-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 06-Apr-2021, the patient experienced TREMOR (hands started shaking) and DIZZINESS (lightheaded).      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 06-Apr-2021, Blood pressure measurement: 118/72. On 06-Apr-2021, Heart rate: 06-apr-2021. On 06-Apr-2021, Oxygen saturation: 06-apr-2021.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   Reporter did not allow further contact
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Fatigue, Induration, Pyrexia, Skin swelling
Clinical narrative: it puffed out; it was really swollen; redness has spread down to her elbow; there's like a hardness to it; fever; tiredness; This spontaneous case was reported by a consumer and describes the occurrence of SKIN SWELLING (it puffed out), SWELLING (it was really swollen), ERYTHEMA (redness has spread down to her elbow), INDURATION (there's like a hardness to it) and PYREXIA (fever) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included PARACETAMOL (TYLENOL) for an unknown indication.    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Apr-2021, the patient experienced SKIN SWELLING (it puffed out), SWELLING (it was really swollen), ERYTHEMA (redness has spread down to her elbow), INDURATION (there's like a hardness to it), PYREXIA (fever) and FATIGUE (tiredness). At the time of the report, SKIN SWELLING (it puffed out), SWELLING (it was really swollen), ERYTHEMA (redness has spread down to her elbow), INDURATION (there's like a hardness to it), PYREXIA (fever) and FATIGUE (tiredness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Swelling
Clinical narrative: it puffed out; it was really swollen; redness has spread down to her elbow; there's like a hardness to it; fever; tiredness; This spontaneous case was reported by a consumer and describes the occurrence of SKIN SWELLING (it puffed out), SWELLING (it was really swollen), ERYTHEMA (redness has spread down to her elbow), INDURATION (there's like a hardness to it) and PYREXIA (fever) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included PARACETAMOL (TYLENOL) for an unknown indication.    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Apr-2021, the patient experienced SKIN SWELLING (it puffed out), SWELLING (it was really swollen), ERYTHEMA (redness has spread down to her elbow), INDURATION (there's like a hardness to it), PYREXIA (fever) and FATIGUE (tiredness). At the time of the report, SKIN SWELLING (it puffed out), SWELLING (it was really swollen), ERYTHEMA (redness has spread down to her elbow), INDURATION (there's like a hardness to it), PYREXIA (fever) and FATIGUE (tiredness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Inappropriate age at vaccine administration; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Inappropriate age at vaccine administration) in a 16-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031M20A and 012L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.    On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 17-Feb-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Inappropriate age at vaccine administration). On 17-Feb-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Inappropriate age at vaccine administration) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  Treatment information was not provided.    This case was linked to MOD-2021-013640 (Patient Link).
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site rash
Clinical narrative: itch 2 days ago which was only once in a while but was more like a faint itch; the area from the injection site turned into a pink color which was rather large (at least 3-4inches and 2inches wide) like a rash.; injection site turned really red; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (injection site turned really red), VACCINATION SITE PRURITUS (itch 2 days ago which was only once in a while but was more like a faint itch) and VACCINATION SITE RASH (the area from the injection site turned into a pink color which was rather large (at least 3-4inches and 2inches wide) like a rash.) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011A21A and 027L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included HYDRALAZINE for Blood pressure, SIMVASTATIN for Cholesterol, HYDROCODONE BITARTRATE, PARACETAMOL (NORCO) for Pain, AMITRIPTYLINE and BROMAZEPAM for an unknown indication.   On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 08-Apr-2021, the patient experienced VACCINATION SITE ERYTHEMA (injection site turned really red). On an unknown date, the patient experienced VACCINATION SITE PRURITUS (itch 2 days ago which was only once in a while but was more like a faint itch) and VACCINATION SITE RASH (the area from the injection site turned into a pink color which was rather large (at least 3-4inches and 2inches wide) like a rash.). At the time of the report, VACCINATION SITE ERYTHEMA (injection site turned really red), VACCINATION SITE PRURITUS (itch 2 days ago which was only once in a while but was more like a faint itch) and VACCINATION SITE RASH (the area from the injection site turned into a pink color which was rather large (at least 3-4inches and 2inches wide) like a rash.) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications reported. No treatment reported
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Dyspepsia, Fatigue, Pain in extremity, Peripheral swelling
Clinical narrative: diarrhea; heartburn; tired, worn out; fever for 3-4 days; 100 F; left arm is red and swollen from elbow to neck; painful arm, couldn't lift; itchy arm; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHEA (diarrhea), PERIPHERAL SWELLING (left arm is red and swollen from elbow to neck), PAIN IN EXTREMITY (painful arm, couldn't lift), PRURITUS (itchy arm) and DYSPEPSIA (heartburn) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Apr-2021, the patient experienced PERIPHERAL SWELLING (left arm is red and swollen from elbow to neck) and PAIN IN EXTREMITY (painful arm, couldn't lift). 07-Apr-2021, the patient experienced PRURITUS (itchy arm). On an unknown date, the patient experienced DIARRHEA (diarrhea), DYSPEPSIA (heartburn), FATIGUE (tired, worn out) and PYREXIA (fever for 3-4 days; 100 F). The patient was treated with CLINDAMYCIN at an unspecified dose and frequency. At the time of the report, DIARRHEA (diarrhea), PERIPHERAL SWELLING (left arm is red and swollen from elbow to neck), PAIN IN EXTREMITY (painful arm, couldn't lift), DYSPEPSIA (heartburn), FATIGUE (tired, worn out) and PYREXIA (fever for 3-4 days; 100 F) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information not provided. List of concomitant medication were not given.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Pyrexia
Clinical narrative: diarrhea; heartburn; tired, worn out; fever for 3-4 days; 100 F; left arm is red and swollen from elbow to neck; painful arm, couldn't lift; itchy arm; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHEA (diarrhea), PERIPHERAL SWELLING (left arm is red and swollen from elbow to neck), PAIN IN EXTREMITY (painful arm, couldn't lift), PRURITUS (itchy arm) and DYSPEPSIA (heartburn) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Apr-2021, the patient experienced PERIPHERAL SWELLING (left arm is red and swollen from elbow to neck) and PAIN IN EXTREMITY (painful arm, couldn't lift). 07-Apr-2021, the patient experienced PRURITUS (itchy arm). On an unknown date, the patient experienced DIARRHEA (diarrhea), DYSPEPSIA (heartburn), FATIGUE (tired, worn out) and PYREXIA (fever for 3-4 days; 100 F). The patient was treated with CLINDAMYCIN at an unspecified dose and frequency. At the time of the report, DIARRHEA (diarrhea), PERIPHERAL SWELLING (left arm is red and swollen from elbow to neck), PAIN IN EXTREMITY (painful arm, couldn't lift), DYSPEPSIA (heartburn), FATIGUE (tired, worn out) and PYREXIA (fever for 3-4 days; 100 F) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information not provided. List of concomitant medication were not given.
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Tested positive for covid-19; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST POSITIVE (Tested positive for covid-19) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SARS-COV-2 TEST POSITIVE (Tested positive for covid-19). At the time of the report, SARS-COV-2 TEST POSITIVE (Tested positive for covid-19) outcome was unknown. Unknown      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications or treatment information was provided.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Fatigue, Headache, Illness, Mobility decreased
Clinical narrative: Can't raise his hand for a day or 2; Coughing; Sinus strain; Sick for 18 hours; Sore arm; Aching all over; Head hurt bad; Fever for 101 degree; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of MOBILITY DECREASED (Can't raise his hand for a day or 2), COUGH (Coughing), SINUS DISORDER (Sinus strain), ILLNESS (Sick for 18 hours) and PAIN IN EXTREMITY (Sore arm) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in 2020.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MOBILITY DECREASED (Can't raise his hand for a day or 2), COUGH (Coughing), SINUS DISORDER (Sinus strain), ILLNESS (Sick for 18 hours), PAIN IN EXTREMITY (Sore arm), MYALGIA (Aching all over), HEADACHE (Head hurt bad), PYREXIA (Fever for 101 degree) and FATIGUE (Fatigue). At the time of the report, MOBILITY DECREASED (Can't raise his hand for a day or 2), COUGH (Coughing), SINUS DISORDER (Sinus strain), ILLNESS (Sick for 18 hours), PAIN IN EXTREMITY (Sore arm), MYALGIA (Aching all over), HEADACHE (Head hurt bad), PYREXIA (Fever for 101 degree) and FATIGUE (Fatigue) was resolving. Not Provided      mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Concurrent medication not provided.   Treatment medication not provided.   This case was linked to MOD-2021-074036 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 12-Apr-2021: Follow-up information received on 14-MAY-2021 contains significant information: The outcome of the events changed from unknown to resolving.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Pain in extremity, Pyrexia, Sinus disorder
Clinical narrative: Can't raise his hand for a day or 2; Coughing; Sinus strain; Sick for 18 hours; Sore arm; Aching all over; Head hurt bad; Fever for 101 degree; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of MOBILITY DECREASED (Can't raise his hand for a day or 2), COUGH (Coughing), SINUS DISORDER (Sinus strain), ILLNESS (Sick for 18 hours) and PAIN IN EXTREMITY (Sore arm) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in 2020.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MOBILITY DECREASED (Can't raise his hand for a day or 2), COUGH (Coughing), SINUS DISORDER (Sinus strain), ILLNESS (Sick for 18 hours), PAIN IN EXTREMITY (Sore arm), MYALGIA (Aching all over), HEADACHE (Head hurt bad), PYREXIA (Fever for 101 degree) and FATIGUE (Fatigue). At the time of the report, MOBILITY DECREASED (Can't raise his hand for a day or 2), COUGH (Coughing), SINUS DISORDER (Sinus strain), ILLNESS (Sick for 18 hours), PAIN IN EXTREMITY (Sore arm), MYALGIA (Aching all over), HEADACHE (Head hurt bad), PYREXIA (Fever for 101 degree) and FATIGUE (Fatigue) was resolving. Not Provided      mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Concurrent medication not provided.   Treatment medication not provided.   This case was linked to MOD-2021-074036 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 12-Apr-2021: Follow-up information received on 14-MAY-2021 contains significant information: The outcome of the events changed from unknown to resolving.
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient received the dose beyond the recommended expiration date; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received the dose beyond the recommended expiration date) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Apr-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received the dose beyond the recommended expiration date). On 11-Apr-2021, EXPIRED PRODUCT ADMINISTERED (Patient received the dose beyond the recommended expiration date) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided. Treatment information was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site inflammation, Injection site warmth, Lethargy, Lipohypertrophy
Clinical narrative: Lethargic; Injection site was very inflamed; Itchy; Sore; injection site hot; injection site redness/ and the size of small ball; Rock hard (injection site); This spontaneous case was reported by a consumer and describes the occurrence of LIPOHYPERTROPHY (Rock hard (injection site)), LETHARGY (Lethargic), INJECTION SITE INFLAMMATION (Injection site was very inflamed), PRURITUS (Itchy) and MYALGIA (Sore) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.    Co-suspect product included non-company product IPRATROPIUM BROMIDE, SALBUTAMOL SULFATE (DUONEB) for an unknown indication.    The patient's past medical history included No adverse event (No relevant medical history provided. ). Concomitant products included MULTIVITAMINS;MINERALS for an unknown indication.   On 08-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient started IPRATROPIUM BROMIDE, SALBUTAMOL SULFATE (DUONEB) (unknown route) at an unspecified dose. On 08-Apr-2021, the patient experienced LIPOHYPERTROPHY (Rock hard (injection site)), INJECTION SITE INFLAMMATION (Injection site was very inflamed), PRURITUS (Itchy), INJECTION SITE WARMTH (injection site hot) and INJECTION SITE ERYTHEMA (injection site redness/ and the size of small ball). On 09-Apr-2021, the patient experienced LETHARGY (Lethargic). On an unknown date, the patient experienced MYALGIA (Sore). At the time of the report, LIPOHYPERTROPHY (Rock hard (injection site)), LETHARGY (Lethargic), INJECTION SITE INFLAMMATION (Injection site was very inflamed), PRURITUS (Itchy), INJECTION SITE WARMTH (injection site hot) and INJECTION SITE ERYTHEMA (injection site redness/ and the size of small ball) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Pruritus
Clinical narrative: Lethargic; Injection site was very inflamed; Itchy; Sore; injection site hot; injection site redness/ and the size of small ball; Rock hard (injection site); This spontaneous case was reported by a consumer and describes the occurrence of LIPOHYPERTROPHY (Rock hard (injection site)), LETHARGY (Lethargic), INJECTION SITE INFLAMMATION (Injection site was very inflamed), PRURITUS (Itchy) and MYALGIA (Sore) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.    Co-suspect product included non-company product IPRATROPIUM BROMIDE, SALBUTAMOL SULFATE (DUONEB) for an unknown indication.    The patient's past medical history included No adverse event (No relevant medical history provided. ). Concomitant products included MULTIVITAMINS;MINERALS for an unknown indication.   On 08-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient started IPRATROPIUM BROMIDE, SALBUTAMOL SULFATE (DUONEB) (unknown route) at an unspecified dose. On 08-Apr-2021, the patient experienced LIPOHYPERTROPHY (Rock hard (injection site)), INJECTION SITE INFLAMMATION (Injection site was very inflamed), PRURITUS (Itchy), INJECTION SITE WARMTH (injection site hot) and INJECTION SITE ERYTHEMA (injection site redness/ and the size of small ball). On 09-Apr-2021, the patient experienced LETHARGY (Lethargic). On an unknown date, the patient experienced MYALGIA (Sore). At the time of the report, LIPOHYPERTROPHY (Rock hard (injection site)), LETHARGY (Lethargic), INJECTION SITE INFLAMMATION (Injection site was very inflamed), PRURITUS (Itchy), INJECTION SITE WARMTH (injection site hot) and INJECTION SITE ERYTHEMA (injection site redness/ and the size of small ball) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Erythema, Fatigue, Hypoaesthesia, Lip swelling
Clinical narrative: Couldn't open her eyes; Whole face and lips are swollen; Whole face and lips are swollen; Red, itchy, "kind of burning" rash on the left side of face and neck; Right thumb is numb; Red, itchy, "kind of burning" rash on the left side of face and neck; Really tired; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (Couldn't open her eyes), SWELLING FACE (Whole face and lips are swollen), LIP SWELLING (Whole face and lips are swollen), PRURITUS (Red, itchy, "kind of burning" rash on the left side of face and neck) and HYPOAESTHESIA (Right thumb is numb) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Asthma. Concomitant products included SALBUTAMOL (VENTOLIN [SALBUTAMOL]) for Asthma.    On 10-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Apr-2021, the patient experienced SOMNOLENCE (Couldn't open her eyes), SWELLING FACE (Whole face and lips are swollen), LIP SWELLING (Whole face and lips are swollen), PRURITUS (Red, itchy, "kind of burning" rash on the left side of face and neck), HYPOAESTHESIA (Right thumb is numb), ERYTHEMA (Red, itchy, "kind of burning" rash on the left side of face and neck) and FATIGUE (Really tired). At the time of the report, SOMNOLENCE (Couldn't open her eyes), SWELLING FACE (Whole face and lips are swollen), LIP SWELLING (Whole face and lips are swollen), PRURITUS (Red, itchy, "kind of burning" rash on the left side of face and neck), HYPOAESTHESIA (Right thumb is numb), ERYTHEMA (Red, itchy, "kind of burning" rash on the left side of face and neck) and FATIGUE (Really tired) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-Apr-2021, Body temperature: 100 (High) Temperature of 100F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication including "Another inhaler" for asthma was reported. Treatment using  was reported.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Somnolence, Swelling face
Clinical narrative: Couldn't open her eyes; Whole face and lips are swollen; Whole face and lips are swollen; Red, itchy, "kind of burning" rash on the left side of face and neck; Right thumb is numb; Red, itchy, "kind of burning" rash on the left side of face and neck; Really tired; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (Couldn't open her eyes), SWELLING FACE (Whole face and lips are swollen), LIP SWELLING (Whole face and lips are swollen), PRURITUS (Red, itchy, "kind of burning" rash on the left side of face and neck) and HYPOAESTHESIA (Right thumb is numb) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Asthma. Concomitant products included SALBUTAMOL (VENTOLIN [SALBUTAMOL]) for Asthma.    On 10-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Apr-2021, the patient experienced SOMNOLENCE (Couldn't open her eyes), SWELLING FACE (Whole face and lips are swollen), LIP SWELLING (Whole face and lips are swollen), PRURITUS (Red, itchy, "kind of burning" rash on the left side of face and neck), HYPOAESTHESIA (Right thumb is numb), ERYTHEMA (Red, itchy, "kind of burning" rash on the left side of face and neck) and FATIGUE (Really tired). At the time of the report, SOMNOLENCE (Couldn't open her eyes), SWELLING FACE (Whole face and lips are swollen), LIP SWELLING (Whole face and lips are swollen), PRURITUS (Red, itchy, "kind of burning" rash on the left side of face and neck), HYPOAESTHESIA (Right thumb is numb), ERYTHEMA (Red, itchy, "kind of burning" rash on the left side of face and neck) and FATIGUE (Really tired) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-Apr-2021, Body temperature: 100 (High) Temperature of 100F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication including "Another inhaler" for asthma was reported. Treatment using  was reported.
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue, SARS-CoV-2 test positive
Clinical narrative: Missed the window for the second dose; Tested positive; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Missed the window for the second dose) and SARS-COV-2 TEST POSITIVE (Tested positive) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Missed the window for the second dose) and SARS-COV-2 TEST POSITIVE (Tested positive). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Missed the window for the second dose) had resolved and SARS-COV-2 TEST POSITIVE (Tested positive) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medication was reported. No concomitant medication was reported.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Feeling abnormal, Gait disturbance, Headache, Illness, Oropharyngeal pain
Clinical narrative: Ache all over; Sinus drain two nights in row; Sore throat; Could not walk had to kneel down to open the fridge.; Feeling so bad; Did not feel like sitting up or lying down; Sore arm" but less painful than the first time; Sick like a dog; Fever; Head hurt real bad; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Ache all over), RHINORRHOEA (Sinus drain two nights in row), OROPHARYNGEAL PAIN (Sore throat), GAIT DISTURBANCE (Could not walk had to kneel down to open the fridge.) and FEELING ABNORMAL (Feeling so bad) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 017B21A and 030A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in 2020.   On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN (Ache all over), RHINORRHOEA (Sinus drain two nights in row), OROPHARYNGEAL PAIN (Sore throat), GAIT DISTURBANCE (Could not walk had to kneel down to open the fridge.), FEELING ABNORMAL (Feeling so bad), FEELING ABNORMAL (Did not feel like sitting up or lying down), PAIN IN EXTREMITY (Sore arm" but less painful than the first time), ILLNESS (Sick like a dog), PYREXIA (Fever ) and HEADACHE (Head hurt real bad). At the time of the report, PAIN (Ache all over), RHINORRHOEA (Sinus drain two nights in row), OROPHARYNGEAL PAIN (Sore throat), GAIT DISTURBANCE (Could not walk had to kneel down to open the fridge.), FEELING ABNORMAL (Feeling so bad), FEELING ABNORMAL (Did not feel like sitting up or lying down), PAIN IN EXTREMITY (Sore arm" but less painful than the first time), ILLNESS (Sick like a dog), PYREXIA (Fever ) and HEADACHE (Head hurt real bad) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Pyrexia: 38.7 (High) 101.7 degree Fahrenheit.         Concurrent medication not provided.  Treatment medication not provided   This case was linked to MOD-2021-074025  (Patient Link).
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, Pain in extremity, Pyrexia, Rhinorrhoea
Clinical narrative: Ache all over; Sinus drain two nights in row; Sore throat; Could not walk had to kneel down to open the fridge.; Feeling so bad; Did not feel like sitting up or lying down; Sore arm" but less painful than the first time; Sick like a dog; Fever; Head hurt real bad; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Ache all over), RHINORRHOEA (Sinus drain two nights in row), OROPHARYNGEAL PAIN (Sore throat), GAIT DISTURBANCE (Could not walk had to kneel down to open the fridge.) and FEELING ABNORMAL (Feeling so bad) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 017B21A and 030A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in 2020.   On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN (Ache all over), RHINORRHOEA (Sinus drain two nights in row), OROPHARYNGEAL PAIN (Sore throat), GAIT DISTURBANCE (Could not walk had to kneel down to open the fridge.), FEELING ABNORMAL (Feeling so bad), FEELING ABNORMAL (Did not feel like sitting up or lying down), PAIN IN EXTREMITY (Sore arm" but less painful than the first time), ILLNESS (Sick like a dog), PYREXIA (Fever ) and HEADACHE (Head hurt real bad). At the time of the report, PAIN (Ache all over), RHINORRHOEA (Sinus drain two nights in row), OROPHARYNGEAL PAIN (Sore throat), GAIT DISTURBANCE (Could not walk had to kneel down to open the fridge.), FEELING ABNORMAL (Feeling so bad), FEELING ABNORMAL (Did not feel like sitting up or lying down), PAIN IN EXTREMITY (Sore arm" but less painful than the first time), ILLNESS (Sick like a dog), PYREXIA (Fever ) and HEADACHE (Head hurt real bad) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Pyrexia: 38.7 (High) 101.7 degree Fahrenheit.         Concurrent medication not provided.  Treatment medication not provided   This case was linked to MOD-2021-074025  (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Palpitations, Vertigo
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (Vertigo (room spinning when she tries to get up from bed).) and PALPITATIONS (occasional palpitations) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.  The patient's past medical history included No adverse event (Medical history was not provided). On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) UNK DF. On 18-Mar-2021, the patient experienced VERTIGO (Vertigo (room spinning when she tries to get up from bed).) and PALPITATIONS (occasional palpitations). At the time of the report, VERTIGO (Vertigo (room spinning when she tries to get up from bed).) had not resolved and PALPITATIONS (occasional palpitations) outcome was unknown. Not Provided. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.